Abstract
Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction – experience from Dubrava University Hospital
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have